Skip to main content

Another article on revamping ADA

Here's another article I found on the move to revamp ADA. It came from Human Resources Executive magazine. It's always a good idea to understand how the HR folks are viewing these issues and what they're saying to one another. Plus, the article makes some good points

Note: The magazine has asked me not to include the entire text of the article, which I'm happy to do. But, as I know several of you repost things from here, I wanted to pass along the request.



Collaboration Leads to Revised ADA Bill

The proposed law will expand narrow court interpretations that have restricted ADA coverage in the workplace for people with disabilities. It is expected to increase the overall number of disabled people able to request reasonable accommodations, but should not have a significant impact on ADA employment policies already in place.

By Tom Starner
Since becoming federal law in 1990, the Americans with Disabilities Act has had a major impact on the U.S. workplace. The problem is, whatever the ADA's net effect has been on employment and the working disabled in general, subsequent legal decisions have led to as much frustration as success.

That court-produced frustration, in turn, has caused both disabled advocates and business leaders to seek out more consistent, fair ADA rules and regulations. It was a rare chance for groups with frequently opposing views to work together.

On Wednesday, those groups came a step closer to resolving any differences (and clarifying specific issues) on the ADA front, when two key committees within the U.S. House of Representatives "marked-up" the ADA Amendments Act of 2008.

The House Judiciary committee approved the measure on a 27-0 vote, and House Education and Labor Committee approved it by a 43 to 1 margin.

To read the rest of the article, go to: http://www.hreonline.com/HRE/story.jsp?storyId=104013393

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria